Preparation method and application of a targeted drug delivery system for extracellular vesicles of *Gnaphalium affine* with liver-repairing effects.

The GA-GELNs drug delivery system, constructed by loading glycyrrhetinic acid onto the extracellular vesicles of *Gynostemma pentaphyllum*, has solved the challenges of liver damage repair and liver cancer treatment, achieving better liver targeting and anti-liver cancer activity, reducing liver damage indicators, and improving biosafety.

CN120661688BActive Publication Date: 2026-11-17XIAMEN MEDICAL COLLEGE
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202510829930.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-06-20
Publication Date
2026-11-17
Estimated Expiration
2045-06-20

AI Technical Summary

Technical Problem

Existing technologies are insufficient to effectively repair liver damage, especially liver cell damage caused by drug-induced liver injury, and traditional drug carriers have insufficient targeting ability and anti-liver cancer activity in the liver.

Method used

Using white phoenix flower extracellular vesicles as carriers, glycyrrhetinic acid (GA) was loaded to construct a GA-GELNs drug delivery system. White phoenix flower extracellular vesicles were extracted and purified by ultracentrifugation and differential centrifugation, and then co-incubated with GA to form a targeted drug delivery system.

Benefits of technology

GA-GELNs significantly improved the inhibitory activity against liver cancer cells and the liver damage repair effect, with better tumor targeting and biosafety, and significantly reduced the levels of liver damage markers ALT and AST.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120661688B_ABST
    Figure CN120661688B_ABST
Patent Text Reader

Abstract

This invention provides a method for preparing and applying a *Gynostemma pentaphyllum* extracellular vesicle targeted drug delivery system with liver-repairing effects. The *Gynostemma pentaphyllum* extracellular vesicle targeted drug delivery system is GA-GELNs, which uses *Gynostemma pentaphyllum* extracellular vesicle GELNs as carriers to load the drug glycyrrhetinic acid (GA), thereby constructing the *Gynostemma pentaphyllum* extracellular vesicle targeted drug delivery system GA-GELNs. This *Gynostemma pentaphyllum* extracellular vesicle targeted drug delivery system achieves better therapeutic effects while improving biocompatibility.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical fields of biomedicine and molecular biology, and specifically relates to a preparation method and application of a Gynura formosana extracellular vesicle targeted drug delivery system with liver injury repairing effect. Background Art

[0002] Liver injury is a severe liver damaging disease mainly characterized by metabolic disorder, internal environment imbalance and liver function loss. It mainly refers to severe liver damage caused by short-term exposure of organisms to large doses of exogenous substances such as chemicals, alcohol, drugs, bacteria and viruses. Long-term liver injury often leads to liver fibrosis, and is also an important predisposing factor for the occurrence of liver cirrhosis and hepatocellular carcinoma.

[0003] Glycyrrhetinic Acid (GA) is a white powder at normal temperature with poor water solubility. It is one of the active components extracted from the root of Glycyrrhiza, a traditional Chinese medicinal plant of the Leguminosae family, and is the aglycone of Glycyrrhizic Acid (GL), with both hydrophilic and hydrophobic properties. Its chemical structure has two isomers, namely 18α-GA and 18β-GA structures. It exerts multiple pharmacological effects such as anti-acid, anti-inflammatory, anti-viral and anti-tumor cell activities by affecting the body's signal transduction pathways and protein expression. When used as a drug carrier to construct a drug loading system, it can significantly improve the in vitro proliferation inhibitory activity against human hepatoma cells compared with the effect of a single drug.

[0004] Gynura formosana ( Gynuraformosana Kitam ) is the whole herb of the perennial herb Gynura formosana belonging to the family Asteraceae ( Compositae ) genus Gynura ( Gynura ), also known as Pianzaihuang grass. It is cool in nature, sweet and mild in taste, non-toxic, and acts on the liver, lung, kidney, large intestine, small intestine and other meridians, with effects such as relieving fever and detoxifying. Its aerial parts are widely used in Fujian, especially in the folk of southern Fujian, and it is a natural Chinese herbal medicine with great research and development value.

[0005] Plant extracellular vesicles (plant extracellular vesicles, EVs.) are membranous vesicles secreted by plant cells, with a specific phospholipid bilayer structure, saucer-shaped or cup-shaped, a particle size of 30 to 300 nm, and containing multiple active components such as lipids, proteins and nucleic acids. Plant extracellular vesicles are similar in structure and function to animal exosomes. Exosomes are messengers for intercellular information exchange and participate in the physiological processes of various diseases in the human body. They have the advantages of good biocompatibility and low immunogenicity, can not only cross biological barriers, but also reflect the physiological and pathological conditions of cells. Summary of the Invention

[0006] Liver injury primarily involves damage to liver cells, leading to abnormalities in liver structure and function. Drug-induced liver injury is the most common type of liver injury, which can result in the accumulation of toxins in the body. The liver's metabolic, detoxification, synthesis, and storage functions may be weakened to varying degrees, interfering with the normal function of other organs and even inducing more serious diseases. This study aimed to extract and purify extracellular vesicles (GELNs) from *Gynostemma pentaphyllum* using C57BL / 6 mice via a combination of ultracentrifugation and differential centrifugation. The morphology and particle size distribution of exosomes were observed using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and zeta potential methods. Protein content was determined while maintaining the structural integrity of the plant vesicle exosomes. A drug delivery system was constructed by loading GA (glucanaceous acid). Using a human hepatocellular carcinoma (HepG2) cancer cell model and a mouse model of liver injury, the anti-hepatocellular carcinoma activity and liver injury repair effects were investigated from the perspectives of cellular indicators and physiological and biochemical indicators.

[0007] To achieve the above objectives, the present invention adopts the following technical solution: A targeted drug delivery system for *Gynostemma pentaphyllum* extracellular vesicles with liver-repairing effects is disclosed. The targeted drug delivery system for *Gynostemma pentaphyllum* extracellular vesicles is GA-GELNs, which uses *Gynostemma pentaphyllum* extracellular vesicles (GELNs) as carriers to load the drug glycyrrhetinic acid (GA), thereby constructing the *Gynostemma pentaphyllum* extracellular vesicle targeted drug delivery system GA-GELNs.

[0008] Preferably, the preparation method of the *GelNs* extracellular vesicles includes the following steps: *GelNs* is added to phosphate buffer and soaked for 5 hours. Then, it is juiced and pulverized using a juicer. The extracted juice is filtered and centrifuged at 4°C in the following order: 1000×g for 10 min, 3000×g for 20 min, and 10000×g for 30 min. The supernatant is collected. The supernatant is centrifuged at 4°C for 2 h at 150000×g using an ultra-high-speed centrifuge. The precipitate is collected. The precipitate is resuspended in PBS, and the resulting suspension is filtered through a 0.22 μm filter membrane to obtain the purified *GelNs* vesicle suspension.

[0009] Preferably, the ratio of white amaranth to phosphate-buffered saline (PBS) is 1:10 g / mL.

[0010] Preferably, the pH of phosphate-buffered saline (PBS) is 7.4.

[0011] Preferably, the preparation method of the *Gynostemma pentaphyllum* extracellular vesicle targeted drug delivery system with liver-repairing effect includes the following steps: GELNs suspension and GA solution are mixed at a mass ratio of 1:2 and incubated together in a shaker at 37°C for 2 h. After centrifugation at 12000 rpm for 10 min, the supernatant is taken to measure the encapsulation rate. Purified water is added to the precipitate, and the mixture is sonicated for 15 min, paused for 5 min, and repeated three times. After centrifugation, the supernatant is taken and transferred to a sample bottle. The supernatant is GA-GELNs. The above sample is taken to measure the drug loading under ultraviolet light, and the drug loading is 38.76%.

[0012] Preferably, the concentration of the GELNs suspension is 2 mg / mL.

[0013] Preferably, the concentration of the GA solution is 1 mg / mL.

[0014] Preferably, in the GA-GELNs extracellular vesicle targeted drug delivery system of *Gynostemma pentaphyllum*, the drug loading of GA is 38.76%.

[0015] Application 1: The application of the *Gnaphalium affine* extracellular vesicle targeted drug delivery system in the preparation of drugs for repairing liver damage.

[0016] Application 2: The application of the above-described *Gnaphalium affine* extracellular vesicle targeted drug delivery system in the preparation of anti-liver cancer drugs.

[0017] The advantages of this invention are: This invention is the first to discover that extracellular vesicles of *Gynostemma pentaphyllum* can effectively inhibit liver tumor cells and repair liver damage. The system of modified *Gynostemma pentaphyllum* extracellular vesicles loaded with glycyrrhetinic acid exhibits better antitumor activity and tumor targeting compared to single *Gynostemma pentaphyllum* extracellular vesicles or glycyrrhetinic acid groups, achieving a synergistic effect of multiple components. Attached Figure Description

[0018] Figure 1 Photograph of the extracellular vesicle suspension of *Gnaphalium affine*; Figure 2 Transmission electron microscopy image of extracellular vesicles of *Gnaphalium affine*. Figure 3 This is a particle size distribution diagram of extracellular vesicles in *Bletilla striata*. Figure 4 The effect of different concentrations of GELNs on the survival rate of HepG2 cells (n=3); Figure 5 The effect of different concentrations of GA on the survival rate of HepG2 cells (n=3); Figure 6 The effect of different concentrations of GA-GELNs on the survival rate of HepG2 cells (n=3); Figure 7These are images of the livers of mice from different groups. Figure 8 These are the levels of ALT and AST in mouse plasma; Figure 9 The images show the pathological morphology of liver tissue in mice in each group (HE, ×400). Note: A (blank control group), B (APAP group), C (low-dose group), D (medium-dose group), E (high-dose group). Detailed Implementation

[0019] To make the above-mentioned features and advantages of the present invention more apparent and understandable, specific embodiments are described below in detail. Unless otherwise specified, the methods of the present invention are conventional methods in the art.

[0020] Example 1 1. Extraction and identification of white phoenix seed vesicles 1.1 Extraction experiment of white ginseng vesicles 1.5 kg of *Hydrocotyle vulgaris* was added to phosphate-buffered saline (PBS, pH = 7.4) pre-cooled to 4°C at a ratio of 1:10 (g / mL). After soaking for 5 hours, the *Hydrocotyle vulgaris* was first juiced and crushed using a juicer. The extracted juice was filtered and centrifuged at 4°C in the following order: 1000×g for 10 min, 3000×g for 20 min, and 10000×g for 30 min. The supernatant was collected. The supernatant was then centrifuged at 4°C for 2 h at a speed of 150000×g using an ultracentrifuge, and the precipitate was collected. The precipitate was resuspended in 10 mL of PBS. The resulting suspension was filtered through a 0.22 μm filter membrane to obtain the purified *Hydrocotyle vulgaris* vesicle suspension.

[0021] 1.2 Identification test of extracellular vesicles of *Gynostemma pentaphyllum* The vesicles of *Gnaphalium affine* obtained by centrifugation were identified by transmission electron microscopy. The specific experimental procedure is as follows: Transfer 10 μL of vesicle suspension onto a wax tray using a pipette. Place a copper mesh with the supporting membrane in contact with the suspension surface. Let it stand for 5 minutes. Remove the copper mesh, blot off excess liquid with filter paper, and allow it to dry slightly. Take a small drop of 3% phosphotungstic acid solution and place it on the wax tray. Place the copper mesh with the sample adsorbed onto the staining solution surface (sample in contact with the staining solution) and let it stand for 3-5 minutes. Remove the copper mesh, blot off excess liquid with filter paper, allow it to dry, and take electron micrographs.

[0022] The specific procedure for nanoparticle analysis of extracellular vesicles in *Bai Feng Cai* (a type of herb) is as follows: The size of GELNs can be analyzed using nanoparticle tracking analysis technology. After diluting the extracted GELN suspension with PBS buffer to an appropriate concentration, information on particle number, particle size, and potential can be obtained.

[0023] 1.3 Preparation of GA-GELNs A 2 mg / mL GELNs suspension was mixed with a 1 mg / mL GA solution at a volume ratio of 2:1 and incubated in a shaker at 37 °C for 2 h. After centrifugation at 12000 rpm for 10 min, the supernatant was collected to measure the encapsulation efficiency. 0.5 g of the precipitate was added to 1 mL of purified water, sonicated for 15 min, paused for 5 min, and repeated three times. After centrifugation, the supernatant was transferred to a sample vial. The supernatant was GA-GELNs. The drug loading was calculated by UV spectroscopy, and the drug loading was 38.76%.

[0024] 2. Evaluation of the efficacy of GA-GELNs in inhibiting hepatocellular carcinoma 2.1 Cell Experiment 2.1.1 HepG2 cell culture HepG2 cells were grown in DMEM high-glucose medium with a serum-penicillin-streptomycin antibiotic ratio of 100:10:1, adhering to the culture dish at 37 ℃ and 5% CO2. The cells typically filled the culture dish within 48-72 hours, at which point they could be passaged or used for subsequent experiments.

[0025] 2.1.2 Cytotoxicity test Experimental group: Cells were treated with three groups of drugs, namely GELNs, GA and GA-CELNs, respectively, and culture media containing different mass concentrations of drugs were prepared.

[0026] Control group: Cells were added to complete culture medium.

[0027] Control group: Cell-free, with only complete culture medium added.

[0028] HepG2 cells in the logarithmic growth phase were seeded at a rate of 1000 cells per well in 96-well plates (n=3). After cell attachment, three groups of drugs (GELNs, GA, and GA-CELNs) were added and cultured for 24 h. Then, CCK-8 solution was added and incubated for 1 h. The absorbance (OD) was measured at 450 nm to analyze the cell viability under different conditions.

[0029] 3. The role of GA-GELNs in repairing liver damage 3.1 Animal grouping and treatment After acclimatization for 2 weeks, 8 C57BL / 6J mice were randomly selected as the control group, and the remaining 32 C57BL / 6 mice were intraperitoneally injected with APAP (400 mg / kg). -1 After establishing a drug-induced liver injury model, participants were randomly divided into an APAP model group and low, medium, and high doses (10 μg / kg) of GA-GELNs. -1 30 μg·kg -180 μg·kg -1 In the tail vein administration group (n=8 per group), mice were administered the drug via tail vein once daily for 7 consecutive days, and their survival status was observed. Twenty-four hours after the last administration, mice were anesthetized, and blood was collected by enucleation into 1.5 mL tubes. After standing for 2 hours, the tubes were centrifuged at 3500×g for 20 min at 4 ℃, and the supernatant was collected and stored at -80 ℃. Simultaneously, liver tissue was collected from the dissected mice, and HE staining was used to examine the pathological morphology of the liver tissue. This study followed the "3R" principle (R, R, R).

[0030] 3.2 Drug delivery system's effect on liver injury repair in mice According to the manufacturer's instructions, the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the plasma of mice in each group were detected using the ALT / ALT activity assay kit and the AST / AST activity assay kit, respectively. The specific operating steps are as follows: Dissolve the lyophilized powder in 2 mL of distilled water to prepare reagent one; dilute 20 μmol / mL sodium pyruvate solution with distilled water to prepare concentrations of 1, 0.8, 0.6, 0.4, 0.2, 0.1, and 0.05 μmol / mL, and pipette 30 μL of each solution into 7 EP tubes, labeled as standard tubes 1-7; take one EP tube and label it as the blank tube, add 30 μL of distilled water, and use it to plot the standard curve; place the standard tube and the blank tube in a 37 ℃ incubator for 30 min, then add 25 μL of reagent two to each, and place them in a 37 ℃ incubator for another 20 min; for each plasma sample, take 2 EP tubes, labeling them as the assay tube and the control tube, respectively. Add 5 μL of plasma and 25 μL of reagent I to the test tube, and add 25 μL of reagent I to the control tube. Mix the two tubes thoroughly and incubate at 37℃ for 30 min. Add 25 μL of reagent II to each of the two tubes, and add 5 μL of plasma to the control tube. Mix the two tubes thoroughly and incubate at 37℃ for another 20 min. Add 240 μL of reagent III to each tube, mix thoroughly, and incubate at room temperature for 10 min. Pipette 200 μL of the reaction solution into each well of a 96-well plate and measure the absorbance at 505 nm using a microplate reader. Label the tubes as A (test tube), A (control tube), A (standard tube), and A (blank tube). Calculate ΔAstandard = Astandard - Ablank, and ΔA = Atest tube - Acontrol. Plot a standard curve with the concentration of each standard as the x-axis and ΔAstandard as the y-axis, obtaining the equation y = kx + b. Substitute ΔA into the equation to calculate the value of x (μmol / mL). GPT / GOT activity (U / mL) = 12x.

[0031] Liver tissue was collected and fixed in 4% paraformaldehyde solution. The tissue was removed from the paraformaldehyde solution, the formaldehyde solution was absorbed with absorbent paper, and the surface of the tissue was trimmed with a blade. The trimmed tissue was then soaked in 70% (4-12h), 80% (4-12h), 90% (1-2h), and 100% (1-2h) ethanol solutions in sequence to displace the formaldehyde solution in the tissue. The tissue was then soaked in xylene solution to displace the ethanol. Soaking was stopped when the tissue edges became translucent. The paraffin wax in an oven was opened in advance and melted. The tissue was then immersed in the paraffin wax for 3 hours, and then placed in another oven containing paraffin wax for 1 hour to displace the xylene in the tissue. Pour molten paraffin into the embedding frame, quickly remove the tissue from the paraffin and place it in the embedding frame with the cut side down, and label it. Keep the paraffin molten throughout the process. To obtain continuous and flat sections, pre-cool the paraffin block containing the tissue sample in a -20°C freezer before sectioning. Fix the paraffin block on the microtome for continuous sectioning. Carefully transfer the sections to 40°C warm water for spreading. Use a glass slide to lift the sections and then place them in an oven to bake. Baking prevents the sections from falling off the slide during staining. After baking, staining can be performed. If staining is not performed immediately after baking, allow the sections to cool to room temperature, then place them in a section box and store in a -20°C freezer. Baking is required again before staining.

[0032] Tissue sections were stained using a hematoxylin-eosin (HE) staining kit. After hematoxylin-eosin staining, the cell nuclei appear blue, and the cytoplasm appears pink or red, allowing for observation of tissues or lesions. Sample preparation: Paraffin sections were dewaxed in xylene for 5–10 min, then dewaxed again in fresh xylene for 5–10 min, followed by anhydrous ethanol for 5 min, 90% ethanol for 2 min, 80% ethanol for 2 min, 70% ethanol for 2 min, and distilled water for 2 min. Hematoxylin-eosin (HE) staining: For the pre-treated samples, hematoxylin staining solution was applied for 5–10 min, followed by rinsing with tap water to remove excess staining solution for approximately 10 min, then rinsing again with distilled water, and finally staining with eosin staining solution for 30 s–2 min. If direct observation is required, the sections can be washed twice with 70% ethanol. If direct observation is not required, dehydration, clearing, and mounting are still necessary after washing with 70% ethanol. After staining, images of each group of tissues were obtained using a microscope.

[0033] Results and Discussion 1. Extraction and isolation of extracellular vesicles from *Bai Feng Zi* (a type of herb) The extracellular vesicle suspension of *Gnaphalium affine* extracted by differential centrifugation combined with ultracentrifugation was yellowish-green (e.g., ...). Figure 1 As shown in the figure, there are no large particles or fibers visible to the naked eye after filtration.

[0034] 1.2 Identification of extracellular vesicles in *Bai Feng Zi* (1) Transmission electron microscopy (TEM) Figure 2 TEM morphological characterization results showed that the extracellular vesicles of *Gnaphalium affine* possessed the typical characteristics of plant extracellular vesicles, with a distinct lipid bilayer, a saucer-like structure, a diameter of about 150 nm, and uniform distribution.

[0035] (2) Nanoparticle tracking analysis (NTA) Figure 3 The particle size analysis of the extracellular vesicles of *Gnaphalium affine* showed that the particle size distribution of the extracellular vesicles was relatively uniform, with an average particle size of about 153.4 nm, and most of them were distributed between 100 and 200 nm.

[0036] 2. Evaluation of the efficacy of GELNs in inhibiting hepatocellular carcinoma 2.1 Cell Experiment 21.1 Evaluation of the inhibitory effect of GA-GELNs on the proliferation of HepG2 cells Experimental results showed that, compared with the blank control group, the GELNs group, GA group, and GA-GELNs group exhibited varying degrees of inhibitory effects on the proliferation of HepG2 cells, and the inhibitory effect was concentration-dependent. The IC50 values ​​of GELNs, GA, and GA-GELNs could be obtained through fitting. 50 The values ​​were 2.045 mg / mL, 87.93 μg / mL, and 60.18 μg / mL, respectively, with IC50 values ​​of 2.045 mg / mL, 87.93 μg / mL, and 60.18 μg / mL. 50 The IC50 value is used to measure the concentration at which a drug produces a half-maximal inhibitory effect. 50 The smaller the value, the better the inhibitory effect on HepG2 cells; therefore, GA-GELNs have a better inhibitory effect on HepG2 cells than GELNs and GA (e.g., ...). Figures 4-6 (As shown).

[0037] 3.2 The role of GA-GELNs in repairing liver damage In the control group, the livers were pale red, well-formed, smooth, delicate, and soft in texture; in the model group, the livers were darker in color, with a rough and uneven surface, visible dark red hemorrhages, and a significantly harder texture; in the low-dose group, the livers were pale red, with a relatively smooth surface, significantly fewer hemorrhages, and a slightly hardened texture; in the medium- and high-dose groups, the livers almost returned to a normal appearance (e.g., Figure 7 (As shown).

[0038] The degree of hepatocellular damage can be assessed by measuring ALT and AST levels. Under normal circumstances, ALT and AST levels in the blood are relatively stable. When hepatocellular cells are damaged, enzymes are released and transferred into the bloodstream, leading to a significant increase in ALT and AST levels. Figure 8 It was found that, compared with the APAP group, the ALT and AST levels in each treatment group were significantly lower, and the ALT and AST levels in the medium- and high-dose groups were significantly lower than those in the model group. This indicates that there are significant differences in ALT and AST levels among different groups, and that each treatment group has a repairing effect on APAP-induced liver cell damage. The differences were statistically significant (ALT:F=318.4). P <0.001; AST:F=124.0, P <0.001).

[0039] HE staining results showed that in the blank control group mice, hepatocytes were tightly packed, with no obvious dilation or compression of the hepatic sinusoids, and no obvious inflammatory changes were observed. Figure 9 In the A;APAP model group of mice, extensive necrosis of liver tissue was observed, with numerous hepatocytes showing pyknosis, deep staining, fragmentation, or lysis, accompanied by inflammation. Figure 9 In the medium- and low-dose groups, mouse liver tissue showed necrosis, with hepatocyte nuclei becoming pyknotted, deeply stained, fragmented, or dissolved, accompanied by inflammation. Figure 9 In the medium-dose group, the liver tissue of mice showed pyknosis and deep staining of hepatocytes, accompanied by a small amount of inflammatory cell infiltration. Figure 9 In the medium- and high-dose groups, no significant expansion or compression was observed in the liver tissue and sinusoids of mice; only mild inflammatory changes were observed. Figure 9 E in Chinese.

[0040] Plant-derived extracellular vesicles not only exert pharmacological effects as active ingredients but also offer unique advantages as drug carriers. This invention has found that *Gynostemma pentaphyllum* extracellular vesicles have a certain therapeutic effect on liver injury. To further investigate the potential anti-hepatocellular carcinoma effect of *Gynostemma pentaphyllum* vesicles, this experiment used differential ultracentrifugation to extract *Gynostemma pentaphyllum* extracellular vesicles, followed by purification and characterization. *Gynostemma pentaphyllum* extracellular vesicles loaded with glycyrrhetinic acid were constructed using a co-incubation method. A mouse model of liver injury was established by intraperitoneal injection of APAP, followed by tail vein injection to explore its in vitro antitumor activity and in vivo biosafety. Structural characterization of GELNs showed that the GELNs prepared in this study were consistent with the evaluation criteria for extracellular vesicles. The system using modified *Gynostemma pentaphyllum* extracellular vesicles loaded with glycyrrhetinic acid exhibited better antitumor activity and tumor targeting compared to other groups. HE staining and serum detection results indicated that it had a therapeutic effect on mouse liver injury, achieving better therapeutic efficacy while improving biosafety.

[0041] The above description is only a preferred embodiment of the present invention. All equivalent changes and modifications made within the scope of the claims of the present invention should be included in the scope of the present invention.

Claims

1. A Gynura japonica extracellular vesicle targeted drug delivery system with a liver damage repairing effect, characterized in that, The extracellular vesicle targeted drug delivery system of *Gynostemma pentaphyllum* is GA-GELNs, which uses *Gynostemma pentaphyllum* extracellular vesicle GELNs as a carrier to load the drug glycyrrhetinic acid GA, thereby constructing the *Gynostemma pentaphyllum* extracellular vesicle targeted drug delivery system GA-GELNs.

2. The *Pterocarya stenoptera* extracellular vesicle targeted drug delivery system with liver-repairing effects according to claim 1, characterized in that, The preparation method of the *GELNs* extracellular vesicles from *Gynostemma pentaphyllum* includes the following steps: *Gynostemma pentaphyllum* is added to phosphate buffer and soaked for 5 hours. Then, it is juiced and pulverized using a juicer. The extracted juice is filtered and centrifuged at 4°C in the following order: 1000×g for 10 min, 3000×g for 20 min, and 10000×g for 30 min. The supernatant is collected. The supernatant is centrifuged at 4°C for 2 h at 150000×g using an ultracentrifuge, and the precipitate is collected. The precipitate is resuspended in PBS, and the resulting suspension is filtered through a 0.22 μm filter membrane to obtain the purified *GELNs* extracellular vesicle suspension.

3. The *Pterocarya stenoptera* extracellular vesicle targeted drug delivery system with liver-repairing effects according to claim 2, characterized in that, The ratio of white amaranth to phosphate-buffered saline (PBS) is 1:10 g / mL.

4. The *Pterocarya stenoptera* extracellular vesicle targeted drug delivery system with liver-repairing effects according to claim 2, characterized in that, The pH of phosphate-buffered saline (PBS) is 7.

4.

5. The preparation method of the *Pterocarya stenoptera* extracellular vesicle targeted drug delivery system with liver-repairing effect according to claim 1, characterized in that, Mix the GELNs suspension with the GA solution at a mass ratio of 1:2 and incubate them together on a shaker at 37°C for 2 h. Centrifuge at 12000 rpm for 10 min, add purified water to the precipitate, sonicate for 15 min, pause for 5 min, repeat three times, and centrifuge at 12000 rpm for 10 min again. After centrifugation, take the supernatant and transfer it to a sample vial. The supernatant is GA-GELNs.

6. The preparation method of the *Acer palmatum* extracellular vesicle targeted drug delivery system with liver-repairing effect according to claim 5, characterized in that, The concentration of the GELNs suspension was 2 mg / mL.

7. The preparation method of the *Acer palmatum* extracellular vesicle targeted drug delivery system with liver-repairing effect according to claim 5, characterized in that, The concentration of the GA solution is 1 mg / mL.

8. The preparation method of the *Acer palmatum* extracellular vesicle targeted drug delivery system with liver-repairing effect according to claim 5, characterized in that, The drug loading of GA in GA-GELNs was 38.76%.

9. The application of the *Gnaphalium affine* extracellular vesicle targeted drug delivery system according to claim 1 in the preparation of drugs for repairing liver damage.

10. The application of the *Gnaphalium affine* extracellular vesicle targeted drug delivery system according to claim 1 in the preparation of anti-liver cancer drugs.

Citation Information

Patent Citations

  • Application of capillary artemisia-derived extracellular vesicle-like nanoparticles in preparation of medicines for preventing or treating liver diseases

    CN119454777A

  • Using water extracts from Taiwanese white amaranth to treat hepatocellular carcinoma and inhibit the growth of hepatocellular carcinoma stem cells.

    TWI661831B